A better understanding of the mechanisms of Peg-IFN-α in the treatment of chronic hepatitis B in combination with TDF can facilitate the discovery of new treatment strategies to cure CHB. This evidence concerns the gene IFNA2 and chronic hepatitis B virus infection.